Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22)

Contemporary Clinical Trials

Volumn 28, Issue 3, 2007, Pages 288-294

  Conwell, Donna Sepulveda ^a   Mosher, Ann ^b   Khan, Awal ^c   Tapy, Jan ^d   Sandman, Laurie ^e   Vernon, Andrew ^c   Horsburgh Jr , C Robert ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^e BELLEVUE HOSPITAL CENTER   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Attrition in clinical trials; Loss to follow up; Retention in clinical trials; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; RIFAPENTINE;

ARTICLE; BIRTH; CANADA; CONFIDENCE INTERVAL; CULTURAL FACTOR; FOLLOW UP; HOMELESSNESS; HOUSING; HUMAN; LANGUAGE ABILITY; MATHEMATICAL MODEL; MULTIVARIATE ANALYSIS; PUBLIC HEALTH SERVICE; RISK; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES;

ANTIBIOTICS, ANTITUBERCULAR; CLINICAL TRIALS, PHASE III; ETHNIC GROUPS; FOLLOW-UP STUDIES; HOMELESS PERSONS; HUMANS; MULTICENTER STUDIES; MULTIVARIATE ANALYSIS; PATIENT DROPOUTS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; REWARD; TUBERCULOSIS, PULMONARY;

EID: 33847264871     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2006.09.003     Document Type: Article

References (25)

1. Moore M.L. Recruitment and retention: nursing research among low-income pregnant women. Appl Nurs Res 3 (1997) 152-158
2. Bender B.G., Ikle D.N., DuHamel T., and Tinkelman D. Retention of asthmatic patients in a longitudinal clinical trial. J Allergy Clin Immunol 2 (1997) 197-203
3. Orr P.R., Blackhurst D.W., and Hawkins B.S. Patient and clinic factors predictive of missed visits and inactive status in a multicenter clinical trial. Control Clin Trials 13 (1992) 40-49
4. Morse E.V., Simon P.M., Besch C.L., and Walker J. Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res 1 (1995) 8-14
5. Mant J. Case control studies. In: Dawes M., Davies P.T., Gray A.M., et al. (Eds). Evidence-based practice: a primer for health care professionals (1999), Harcourt Publishers Limited, London
6. Moser D.K., Dracup K., and Doering L.V. Factors differentiating dropouts from completers in a longitudinal, multicenter clinical trial. Nurs Res 49 (2000) 109-116
7. Friedland D.J. Guide for assessing the validity of a study. In: Friedland D.J. (Ed). Evidence-based medicine: a framework for clinical practice (1998), Appleton and Lange, Stamford
8. Collins J.F., Bingham S.R., Williford W.O., and Weiss D.G. Who drops out of clinical trials - the VA cooperative study experience (abstract). Control Clin Trials 2 (1981) 78
9. Pekovic V., Mayanja H., Vjecha M., et al. Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. J Clin Epidemiol 7 (1998) 597-607
10. Cassidy E.L., Baird E., and Sheikh J.I. Recruitment and retention of elderly patients in clinical trials. Am J Geriatr Psychiatry 9 (2001) 136-140
11. Hunt J.R., and White E. Retaining and tracking cohort study members. Epidemiol Rev 1 (1998) 57-70
12. Brown D.R., Fouad M.N., Basen-Engquist K., and Tortolero-Luna G. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol 10 (2000) S13-S21
13. Neill K.M., and Chessa F. Recruitment and retention of women in nontherapeutic clinical trials. Appl Nurs Res 3 (1998) 148-151
14. Greenberger P., and Knab S. Society workshop investigates barriers to recruitment and retention of women in clinical research. J Women's Health Gend -Based Med 9 (2000) 817-818
15. Wilcox S., Shumaker S.A., Bowen D.J., et al. Promoting adherence and retention to clinical trials in special populations. Control Clin Trials 22 (2001) 279-289
16. Janson S.L., et al., for the Asthma Clinical Research Network. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial. Control Clin Trials 22 6 Suppl (2001) S236-S243
17. Goldman A.I., Holcomb R., Perry H.M., et al. Can dropout and other noncompliance be minimized in a clinical trial?. Control Clin Trials 3 (1982) 75-89
18. Gorelick P.B., Harris Y., Burnett B., and Bonecutter F.J. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. J Natl Med Assoc 90 (1998) 141-145
19. Ickovics J.R., and Meisler A.W. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol 4 (1997) 385-391
20. Tuberculosis Trials Consortium. Once-weekly rifapentine and isoniazid versus twice-weekly rifampin and isoniazid in the continuation phase of therapy for drug-susceptible pulmonary tuberculosis: a prospective, randomized clinical trial among HIV-negative persons. Lancet 360 (2002) 528-534
21. Zolopa A.R., Hahn J.A., Gorter R., et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample. JAMA 272 (1994) 455-461
22. Blumenthal D.S., Sung J., Coates R., et al. Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. Health Serv Res 30 (1995) 197-205
23. CDC. Reported tuberculosis in the United States, 2002 (September 2003), U.S. Department of Health and Human Services, CDC, Atlanta, GA
24. Goldberg S.V., Wallace J., Jackson C.J., et al. Cultural case management for latent tuberculosis infection. Int J Tuberc Lung Dis 8 (2004) 76-82
25. Dickert N., and Grady C. What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 341 3 (Jul 15 1999) 198-203